Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
Br J Cancer
; 123(2): 226-239, 2020 07.
Article
in En
| MEDLINE
| ID: mdl-32390005
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasm Recurrence, Local
Limits:
Animals
/
Humans
Language:
En
Journal:
Br J Cancer
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom